|
1
|
Hsu NY, Ho HC, Chow KC, et al:
Overexpression of dihydrodiol dehydrogenase as a prognostic marker
of non-small cell lung cancer. Cancer Res. 61:2727–2731.
2001.PubMed/NCBI
|
|
2
|
Chen CY, Hsu CP, Hsu NY, Shih CS, Lin TY
and Chow KC: Expression of dihydrodiol dehydrogenase in the
resected stage I non-small cell lung cancer. Oncol Rep. 9:515–519.
2002.PubMed/NCBI
|
|
3
|
Huang KH, Chiou SH, Chow KC, et al:
Overexpression of aldo-keto reductase 1C2 is associated with
disease progression in patients with prostatic cancer.
Histopathology. 57:384–394. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen H, Kauvar L and Tew KD: Importance of
glutathione and associated enzymes in drug response. Oncol Res.
9:295–302. 1997.PubMed/NCBI
|
|
5
|
Ax W, Soldan M, Koch L and Maser E:
Development of daunorubicin resistance in tumour cells by induction
of carbonyl reduction. Biochem Pharmacol. 59:293–300. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shou M, Harvey RG and Penning TM:
Contribution of dihydrodiol dehydrogenase to the metabolism of
(+/−)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in fortified
rat liver subcellular fractions. Carcinogenesis. 13:1575–1582.
1992.PubMed/NCBI
|
|
7
|
Flowers-Geary L, Harvey RG and Penning TM:
Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat
and human hepatoma cells. Chem Res Toxicol. 6:252–260. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deng HB, Parekh HK, Chow KC and Simpkins
H: Increased expression of dihydrodiol dehydrogenase induces
resistance to cisplatin in human ovarian carcinoma cells. J Biol
Chem. 277:15035–15043. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chow KC, MacDonald TL and Ross WE: DNA
binding by epipodophyllotoxins and N-acyl anthracyclines:
implications for mechanism of topoisomerase II inhibition. Mol
Pharmacol. 34:467–473. 1988.PubMed/NCBI
|
|
10
|
Hill BT, Shellard SA, Hosking LK,
Fichtinger-Schepman AM and Bedford P: Enhanced DNA repair and
tolerance of DNA damage associated with resistance to
cis-diammine-dichloroplatinum (II) after in vitro exposure of a
human teratoma cell line to fractionated X-irradiation. Int J
Radiat Oncol Biol Phys. 19:75–83. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sorenson CM and Eastman A: Mechanism of
cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2
arrest and DNA double-strand breaks. Cancer Res. 48:4484–4488.
1988.PubMed/NCBI
|
|
12
|
Hung JJ, Chow KC, Wang HW and Wang LS:
Expression of dihydrodiol dehydrogenase and resistance to
chemotherapy and radiotherapy in adenocarcinoma cells of lung.
Anticancer Res. 26:2949–2955. 2006.PubMed/NCBI
|
|
13
|
Wang LS, Chow KC, Wu YC, Lin TY and Li WY:
Inverse expression of dihydrodiol dehydrogenase and
glutathione-S-transferase in patients with esophageal squamous cell
carcinoma. Int J Cancer. 111:246–251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chow KC, Lu MP and Wu MT: Expression of
dihydrodiol dehydrogenase plays important roles in apoptosis- and
drug-resistance of A431 squamous cell carcinoma. J Dermatol Sci.
41:205–212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ueda M, Hung YC, Chen JT, et al: Infection
of human papillomavirus and overexpression of dihydrodiol
dehydrogenase in uterine cervical cancer. Gynecol Oncol.
102:173–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tai HL, Lin TS, Huang HH, et al:
Overexpression of aldo-keto reductase 1C2 as a high-risk factor in
bladder cancer. Oncol Rep. 17:305–311. 2007.PubMed/NCBI
|
|
17
|
Chang HC, Chen YL, Chan CP, et al:
Overexpression of dihydrodiol dehydrogenase as a prognostic marker
in resected gastric cancer patients. Dig Dis Sci. 54:342–347. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Adikari M, Pallai R, Parekh HK and
Simpkins H: Dihydrodiol dehydrogenases regulate the generation of
reactive oxygen species and the development of cisplatin resistance
in human ovarian carcinoma cells. Cancer Chemother Pharmacol.
61:979–987. 2008. View Article : Google Scholar
|
|
19
|
Chen J, Emara N, Solomides C, Parekh H and
Simpkins H: Resistance to platinum-based chemotherapy in lung
cancer cell lines. Cancer Chemother Pharmacol. 66:1103–1111. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kruidering M, Van de Water B, de Heer E,
Mulder GJ and Nagelkerke JF: Cisplatin-induced nephrotoxicity in
porcine proximal tubular cells: mitochondrial dysfunction by
inhibition of complexes I to IV of the respiratory chain. J
Pharmacol Exp Ther. 280:638–649. 1997.
|
|
21
|
Chow KC, King CK and Ross WE: Abrogation
of etoposide-mediated cytotoxicity by cycloheximide. Biochem
Pharmacol. 37:1117–1122. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiang SF, Huang CY, Lin TY, Chiou SH and
Chow KC: An alternative import pathway of AIF to the mitochondria.
Int J Mol Med. 29:365–372. 2012.PubMed/NCBI
|
|
23
|
Yoon Y, Pitts KR, Dahan S and McNiven MA:
A novel dynamin-like protein associates with cytoplasmic vesicles
and tubules of the endoplasmic reticulum in mammalian cells. J Cell
Biol. 140:779–793. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang HY, Chang CL, Hsu SH, et al: The
ATPase family, AAA domain containing 3A is a novel anti-apoptotic
factor in lung adenocarcinoma cells. J Cell Sci. 123:1171–1180.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aiyama R, Nagai H, Nokata K, Shinohara C
and Sawada S: A camptothecin derivative from Nothapodytes
foetida. Phytochemistry. 27:3663–3664. 1988. View Article : Google Scholar
|
|
26
|
Kwon HJ and Park YD: Determination of
astragalin and astragaloside content in Radix Astragali using
high-performance liquid chromatography coupled with pulsed
amperometric detection. J Chromatogr A. 1232:212–217. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng W, Kollmeyer J, Symolon H, et al:
Ceramides and other bioactive sphingolipid backbones in health and
disease: lipidomic analysis, metabolism and roles in membrane
structure, dynamics, signaling and autophagy. Biochim Biophys Acta.
1758:1864–1884. 2006. View Article : Google Scholar
|
|
28
|
Lin TS, Huang HH, Fan YH, Chiou SH and
Chow KC: Genetic polymorphism and gene expression of microsomal
epoxide hydrolase in non-small cell lung cancer. Oncol Rep.
17:565–572. 2007.PubMed/NCBI
|
|
29
|
Nie C, Tian C, Zhao L, Petit PX, Mehrpour
M and Chen Q: Cysteine 62 of Bax is critical for its conformational
activation and its proapoptotic activity in response to
H2O2-induced apoptosis. J Biol Chem.
283:15359–15369. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Szabò I, Soddemann M, Leanza L, Zoratti M
and Gulbins E: Single-point mutations of a lysine residue change
function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse
embryonic fibroblasts: novel insights into the molecular mechanisms
of Bax-induced apoptosis. Cell Death Differ. 18:427–438. 2011.
|
|
31
|
Griparic L, van der Wel NN, Orozco IJ,
Peters PJ and van der Bliek AM: Loss of the intermembrane space
protein Mgm1/OPA1 induces swelling and localized constrictions
along the lengths of mitochondria. J Biol Chem. 279:18792–18798.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang HY, Chen CY, Chiou SH, et al:
Overexpression of OPA1 protein increases cisplatin resistance via
inactivation of caspase-dependent apoptosis in lung adenocarcinoma
cells. Hum Pathol. 43:105–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chiang YY, Chen SL, Hsiao YT, et al:
Nuclear expression of dynamin-related protein 1 in lung
adenocarcinomas. Mod Pathol. 22:1139–1150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Brito OM and Scorrano L: Mitofusin 2
tethers endoplasmic reticulum to mitochondria. Nature. 456:605–610.
2008.PubMed/NCBI
|
|
35
|
Merkwirth C and Langer T: Mitofusin 2
builds a bridge between ER and mitochondria. Cell. 135:1165–1167.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scarlatti F, Bauvy C, Ventruti A, et al:
Ceramide-mediated macroautophagy involves inhibition of protein
kinase B and up-regulation of beclin 1. J Biol Chem.
279:18384–18391. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hill CP and Babst M: Structure and
function of the membrane deformation AAA ATPase Vps4. Biochim
Biophys Acta. 1823:172–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishibashi K, Fujita N, Kanno E, et al:
Atg16L2, a novel isoform of mammalian Atg16L that is not essential
for canonical autophagy despite forming an Atg12-5-16L2 complex.
Autophagy. 7:1500–1513. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vogel K, Bentley P, Platt KL and Oesch F:
Rat liver cytoplasmic dihydrodiol dehydrogenase. Purification to
apparent homogeneity and properties. J Biol Chem. 255:9621–9625.
1980.PubMed/NCBI
|
|
40
|
Glatt HR, Vogel K, Bentley P and Oesch F:
Reduction of benzo(a)-pyrene mutagenicity by dihydrodiol
dehydrogenase. Nature. 277:319–320. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Penning TM: Dihydrodiol dehydrogenase and
its role in polycyclic aromatic hydrocarbon metabolism. Chem Biol
Interact. 89:1–34. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang HW, Lin CP, Chiu JH, et al: Reversal
of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and
AKR1C2) overexpression and drug resistance in nonsmall cell lung
cancer cells by wogonin and chrysin. Int J Cancer. 120:2019–2027.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen CY, Fang HY, Chiou SH, et al:
Sumoylation of eukaryotic elongation factor 2 is vital for protein
stability and anti-apoptotic activity in lung adenocarcinoma cells.
Cancer Sci. 102:1582–1589. 2011. View Article : Google Scholar : PubMed/NCBI
|
